Pulmonx Statistics
Total Valuation
Pulmonx has a market cap or net worth of $105.88 million. The enterprise value is $74.12 million.
Important Dates
The next estimated earnings date is Wednesday, July 30, 2025, after market close.
| Earnings Date | Jul 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Pulmonx has 40.26 million shares outstanding. The number of shares has increased by 3.14% in one year.
| Current Share Class | 40.26M |
| Shares Outstanding | 40.26M |
| Shares Change (YoY) | +3.14% |
| Shares Change (QoQ) | +0.94% |
| Owned by Insiders (%) | 2.62% |
| Owned by Institutions (%) | 90.65% |
| Float | 39.20M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.19 |
| Forward PS | 1.03 |
| PB Ratio | 1.36 |
| P/TBV Ratio | 1.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.85 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.97, with a Debt / Equity ratio of 0.73.
| Current Ratio | 4.97 |
| Quick Ratio | 4.14 |
| Debt / Equity | 0.73 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -16.45 |
Financial Efficiency
Return on equity (ROE) is -60.68% and return on invested capital (ROIC) is -24.51%.
| Return on Equity (ROE) | -60.68% |
| Return on Assets (ROA) | -22.21% |
| Return on Invested Capital (ROIC) | -24.51% |
| Return on Capital Employed (ROCE) | -44.53% |
| Revenue Per Employee | $300,595 |
| Profits Per Employee | -$196,196 |
| Employee Count | 291 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 1.36 |
Taxes
In the past 12 months, Pulmonx has paid $449,000 in taxes.
| Income Tax | 449,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.84% in the last 52 weeks. The beta is 0.52, so Pulmonx's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | -56.84% |
| 50-Day Moving Average | 3.63 |
| 200-Day Moving Average | 6.11 |
| Relative Strength Index (RSI) | 33.87 |
| Average Volume (20 Days) | 365,239 |
Short Selling Information
The latest short interest is 1.34 million, so 3.32% of the outstanding shares have been sold short.
| Short Interest | 1.34M |
| Short Previous Month | 1.56M |
| Short % of Shares Out | 3.32% |
| Short % of Float | 3.41% |
| Short Ratio (days to cover) | 3.05 |
Income Statement
In the last 12 months, Pulmonx had revenue of $87.47 million and -$57.09 million in losses. Loss per share was -$1.45.
| Revenue | 87.47M |
| Gross Profit | 64.27M |
| Operating Income | -56.01M |
| Pretax Income | -57.29M |
| Net Income | -57.09M |
| EBITDA | -54.67M |
| EBIT | -56.01M |
| Loss Per Share | -$1.45 |
Full Income StatementBalance Sheet
The company has $88.70 million in cash and $56.95 million in debt, giving a net cash position of $31.75 million or $0.79 per share.
| Cash & Cash Equivalents | 88.70M |
| Total Debt | 56.95M |
| Net Cash | 31.75M |
| Net Cash Per Share | $0.79 |
| Equity (Book Value) | 77.67M |
| Book Value Per Share | 1.93 |
| Working Capital | 98.99M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$32.96 million and capital expenditures -$1.30 million, giving a free cash flow of -$34.26 million.
| Operating Cash Flow | -32.96M |
| Capital Expenditures | -1.30M |
| Free Cash Flow | -34.26M |
| FCF Per Share | -$0.85 |
Full Cash Flow StatementMargins
Gross margin is 73.47%, with operating and profit margins of -64.04% and -65.27%.
| Gross Margin | 73.47% |
| Operating Margin | -64.04% |
| Pretax Margin | -64.76% |
| Profit Margin | -65.27% |
| EBITDA Margin | -62.49% |
| EBIT Margin | -64.04% |
| FCF Margin | n/a |
Dividends & Yields
Pulmonx does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.14% |
| Shareholder Yield | -3.14% |
| Earnings Yield | -53.92% |
| FCF Yield | -32.36% |
Analyst Forecast
The average price target for Pulmonx is $11.53, which is 335.09% higher than the current price. The consensus rating is "Buy".
| Price Target | $11.53 |
| Price Target Difference | 335.09% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 32.19% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Pulmonx has an Altman Z-Score of -2.04 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.04 |
| Piotroski F-Score | 3 |
